CHI SHENG PHARMA & BIOTECH CO LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of 4111 for the last quarter is 284.25 M TWD, and it's 0.61% higher compared to the previous quarter. The net income of Q3 24 is 20.17 M TWD.